Improving diagnosis and prognosis of lung cancer using vision
transformers: A scoping review
- URL: http://arxiv.org/abs/2309.02783v1
- Date: Wed, 6 Sep 2023 06:49:31 GMT
- Title: Improving diagnosis and prognosis of lung cancer using vision
transformers: A scoping review
- Authors: Hazrat Ali, Farida Mohsen, Zubair Shah
- Abstract summary: Recently, many researchers have developed vision transformer-based AI methods for lung cancer diagnosis and prognosis.
This scoping review aims to identify the recent developments on vision transformer-based AI methods for lung cancer imaging applications.
- Score: 0.39901365062418304
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: Vision transformer-based methods are advancing the field of medical
artificial intelligence and cancer imaging, including lung cancer applications.
Recently, many researchers have developed vision transformer-based AI methods
for lung cancer diagnosis and prognosis. This scoping review aims to identify
the recent developments on vision transformer-based AI methods for lung cancer
imaging applications. It provides key insights into how vision transformers
complemented the performance of AI and deep learning methods for lung cancer.
Furthermore, the review also identifies the datasets that contributed to
advancing the field. Of the 314 retrieved studies, this review included 34
studies published from 2020 to 2022. The most commonly addressed task in these
studies was the classification of lung cancer types, such as lung squamous cell
carcinoma versus lung adenocarcinoma, and identifying benign versus malignant
pulmonary nodules. Other applications included survival prediction of lung
cancer patients and segmentation of lungs. The studies lacked clear strategies
for clinical transformation. SWIN transformer was a popular choice of the
researchers; however, many other architectures were also reported where vision
transformer was combined with convolutional neural networks or UNet model. It
can be concluded that vision transformer-based models are increasingly in
popularity for developing AI methods for lung cancer applications. However,
their computational complexity and clinical relevance are important factors to
be considered for future research work. This review provides valuable insights
for researchers in the field of AI and healthcare to advance the
state-of-the-art in lung cancer diagnosis and prognosis. We provide an
interactive dashboard on lung-cancer.onrender.com/.
Related papers
- Application analysis of ai technology combined with spiral CT scanning
in early lung cancer screening [15.6839495538166]
The overall 5-year survival rate of lung cancer patients is still lower than 20% and is staged.
In recent years, artificial intelligence technology has gradually begun to be applied in oncology.
This study applied the combined method in early lung cancer screening, aiming to find a safe and efficient screening mode.
arXiv Detail & Related papers (2024-01-26T07:58:09Z) - Cancer-Net PCa-Gen: Synthesis of Realistic Prostate Diffusion Weighted
Imaging Data via Anatomic-Conditional Controlled Latent Diffusion [68.45407109385306]
In Canada, prostate cancer is the most common form of cancer in men and accounted for 20% of new cancer cases for this demographic in 2022.
There has been significant interest in the development of deep neural networks for prostate cancer diagnosis, prognosis, and treatment planning using diffusion weighted imaging (DWI) data.
In this study, we explore the efficacy of latent diffusion for generating realistic prostate DWI data through the introduction of an anatomic-conditional controlled latent diffusion strategy.
arXiv Detail & Related papers (2023-11-30T15:11:03Z) - Variational Autoencoders for Feature Exploration and Malignancy
Prediction of Lung Lesions [0.0]
Lung cancer is responsible for 21% of cancer deaths in the UK.
Recent studies have demonstrated the capability of AI methods for accurate and early diagnosis of lung cancer from routine scans.
This study investigates the application Variational Autoencoders (VAEs), a type of generative AI model, to lung cancer lesions.
arXiv Detail & Related papers (2023-11-27T11:12:33Z) - Cancer-Net BCa-S: Breast Cancer Grade Prediction using Volumetric Deep
Radiomic Features from Synthetic Correlated Diffusion Imaging [82.74877848011798]
The prevalence of breast cancer continues to grow, affecting about 300,000 females in the United States in 2023.
The gold-standard Scarff-Bloom-Richardson (SBR) grade has been shown to consistently indicate a patient's response to chemotherapy.
In this paper, we study the efficacy of deep learning for breast cancer grading based on synthetic correlated diffusion (CDI$s$) imaging.
arXiv Detail & Related papers (2023-04-12T15:08:34Z) - A Multi-Institutional Open-Source Benchmark Dataset for Breast Cancer
Clinical Decision Support using Synthetic Correlated Diffusion Imaging Data [82.74877848011798]
Cancer-Net BCa is a multi-institutional open-source benchmark dataset of volumetric CDI$s$ imaging data of breast cancer patients.
Cancer-Net BCa is publicly available as a part of a global open-source initiative dedicated to accelerating advancement in machine learning to aid clinicians in the fight against cancer.
arXiv Detail & Related papers (2023-04-12T05:41:44Z) - Deep learning methods for drug response prediction in cancer:
predominant and emerging trends [50.281853616905416]
Exploiting computational predictive models to study and treat cancer holds great promise in improving drug development and personalized design of treatment plans.
A wave of recent papers demonstrates promising results in predicting cancer response to drug treatments while utilizing deep learning methods.
This review allows to better understand the current state of the field and identify major challenges and promising solution paths.
arXiv Detail & Related papers (2022-11-18T03:26:31Z) - Enhancing Clinical Support for Breast Cancer with Deep Learning Models
using Synthetic Correlated Diffusion Imaging [66.63200823918429]
We investigate enhancing clinical support for breast cancer with deep learning models.
We leverage a volumetric convolutional neural network to learn deep radiomic features from a pre-treatment cohort.
We find that the proposed approach can achieve better performance for both grade and post-treatment response prediction.
arXiv Detail & Related papers (2022-11-10T03:02:12Z) - Efficient Lung Cancer Image Classification and Segmentation Algorithm
Based on Improved Swin Transformer [0.0]
transformer model has been applied to the field of computer vision (CV) after its success in natural language processing (NLP)
This paper creatively proposes a segmentation method based on efficient transformer and applies it to medical image analysis.
The algorithm completes the task of lung cancer classification and segmentation by analyzing lung cancer data, and aims to provide efficient technical support for medical staff.
arXiv Detail & Related papers (2022-07-04T15:50:06Z) - Multi-Scale Hybrid Vision Transformer for Learning Gastric Histology:
AI-Based Decision Support System for Gastric Cancer Treatment [50.89811515036067]
Gastric endoscopic screening is an effective way to decide appropriate gastric cancer (GC) treatment at an early stage, reducing GC-associated mortality rate.
We propose a practical AI system that enables five subclassifications of GC pathology, which can be directly matched to general GC treatment guidance.
arXiv Detail & Related papers (2022-02-17T08:33:52Z) - Classification of Histopathology Images of Lung Cancer Using
Convolutional Neural Network (CNN) [0.2578242050187029]
Cancer is the uncontrollable cell division of abnormal cells inside the human body, which can spread to other body organs.
It is one of the non-communicable diseases (NCDs) and NCDs accounts for 71% of total deaths worldwide.
Lung cancer is the second most diagnosed cancer after female breast cancer. Cancer survival rate of lung cancer is only 19%.
arXiv Detail & Related papers (2021-12-27T07:43:58Z) - Early Diagnosis of Lung Cancer Using Computer Aided Detection via Lung
Segmentation Approach [0.1749935196721634]
American Cancer Society estimates about 27% of the deaths because of cancer.
In the early phase of its evolution, lung cancer does not cause any symptoms usually.
Many of the patients have been diagnosed in a developed phase where symptoms become more prominent, that results in poor curative treatment and high mortality rate.
arXiv Detail & Related papers (2021-07-23T05:46:06Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.